Cite
HARVARD Citation
Lee, A. et al. (2017). UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice. British journal of ophthalmology. 101 (12), pp. 1683-1688. [Online].